ES355121A1 - Procedure for the preparation of an antigen-free vaccine. (Machine-translation by Google Translate, not legally binding) - Google Patents
Procedure for the preparation of an antigen-free vaccine. (Machine-translation by Google Translate, not legally binding)Info
- Publication number
- ES355121A1 ES355121A1 ES355121A ES355121A ES355121A1 ES 355121 A1 ES355121 A1 ES 355121A1 ES 355121 A ES355121 A ES 355121A ES 355121 A ES355121 A ES 355121A ES 355121 A1 ES355121 A1 ES 355121A1
- Authority
- ES
- Spain
- Prior art keywords
- antigen
- informationally
- viruses
- influenza
- competent cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Vaccines which are antigen-free and comprise aqueous suspensions of informationally active ribonucleic acid are prepared by stimulating with an antigen corresponding to the required informationally active RNA as system of immunologically competent cells or a cellfree system obtained therefrom, and isolating an aqueous suspension of the informationally active RNA. The vaccine may also contain an adjuvant such as aluminium hydroxide or phosphate and/or a pharmaceutically suitable carrier. The immunologically competent cells may be from human or animal lymphs, lymph nodes, spleen, peritoneal exudates and pheripheral leukocytes (blood). The antigen used may be from bacteria, viruses or their subunits or snake poison, e.g. tetanus and diphtheria toxin the products of metabolism or degradation of Bordetella pertussio, Mycobacterlium tuberculosis, salmonellae, shigellae, brucellae influenza, influenza haemagglutinim, polio viruses or their protein envelope, measles, rabies, foot and mouth disease, smallpox, swine fever, distemper, hepatitis contagiosa canis and encephalitis viruses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEJ0033936 | 1967-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES355121A1 true ES355121A1 (en) | 1969-11-16 |
Family
ID=7204943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES355121A Expired ES355121A1 (en) | 1967-06-19 | 1968-06-18 | Procedure for the preparation of an antigen-free vaccine. (Machine-translation by Google Translate, not legally binding) |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT282821B (en) |
| BE (1) | BE716806A (en) |
| BR (1) | BR6899970D0 (en) |
| CH (1) | CH513241A (en) |
| DE (1) | DE1617545C2 (en) |
| DK (1) | DK119724B (en) |
| ES (1) | ES355121A1 (en) |
| FR (2) | FR1588820A (en) |
| GB (1) | GB1229888A (en) |
| IE (1) | IE32140B1 (en) |
| IL (1) | IL30168A (en) |
| NL (1) | NL6808486A (en) |
| NO (1) | NO124840B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754934A (en) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | RNA-MESSENGER ENZYMATIC PRODUCTION PROCESS |
| GB1594097A (en) | 1976-12-16 | 1981-07-30 | Int Inst Of Differentiation | Production of specific immune nucleic acids cell dialysates and antibodies |
| DE3115559A1 (en) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | HIGH PURIFIED INFORMATIVE RIBONUCLEIC ACID (I-RNS), METHOD FOR THE PRODUCTION AND USE THEREOF |
| GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/en not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 CH CH893668A patent/CH513241A/en not_active IP Right Cessation
- 1968-06-17 AT AT576668A patent/AT282821B/en not_active IP Right Cessation
- 1968-06-17 IE IE713/68A patent/IE32140B1/en unknown
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-18 ES ES355121A patent/ES355121A1/en not_active Expired
- 1968-06-18 DK DK286268AA patent/DK119724B/en unknown
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/en unknown
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1617545C2 (en) | 1983-11-03 |
| DK119724B (en) | 1971-02-15 |
| NL6808486A (en) | 1968-12-20 |
| IE32140L (en) | 1968-12-19 |
| CH513241A (en) | 1971-09-30 |
| GB1229888A (en) | 1971-04-28 |
| IL30168A (en) | 1973-05-31 |
| IE32140B1 (en) | 1973-04-18 |
| FR7781M (en) | 1970-03-23 |
| DE1617545A1 (en) | 1971-04-01 |
| FR1588820A (en) | 1970-03-16 |
| IL30168A0 (en) | 1968-08-22 |
| BR6899970D0 (en) | 1973-02-13 |
| BE716806A (en) | 1968-12-19 |
| NO124840B (en) | 1972-06-12 |
| AT282821B (en) | 1970-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wiktor et al. | Cultivation of rabies virus in human diploid cell strain WI-38 | |
| Wiktor et al. | Human cell culture rabies vaccine: antibody response in man | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Sundquist et al. | Influenza virus ISCOMs: antibody response in animals | |
| Webster et al. | Potentiation of the immune response to influenza virus subunit vaccines | |
| Carter et al. | Serologic response of children to inactivated measles vaccine | |
| JP5712126B2 (en) | Rapid response to delayed boost immunization | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| Örvell et al. | Further studies on the immunologic relationships among measles, distemper, and rinderpest viruses | |
| Nicholson et al. | Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon | |
| Atanasiu et al. | Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3 | |
| Schoenbaum et al. | Pseudorabies virus latency and reactivation in vaccinated swine | |
| ES355121A1 (en) | Procedure for the preparation of an antigen-free vaccine. (Machine-translation by Google Translate, not legally binding) | |
| US3927208A (en) | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them | |
| Zinkernagel | Antiviral T-cell memory? | |
| Glasgow et al. | Isoprinosine: lack of antiviral activity in experimental model infections | |
| Saidi et al. | Subcutaneous and intranasal administration of RA 27/3 rubella vaccine: alone and in conjunction with live attenuated measles vaccine | |
| Musser et al. | Measles virus growth in canine renal cell cultures | |
| MOGABGAB | Upper respiratory illness vaccines: Perspectives and trials | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| US3629413A (en) | Polyvalent bovine vaccines and methods of making and using same | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| Millian et al. | Antibody response of man to canine distemper virus | |
| Musser et al. | Production of rubella virus vaccine: Live, attenuated in canine renal cell cultures | |
| McLaren et al. | Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization |